InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Vogelbaum Martin, 董事. Officer active across 1 company, notably Cara Therapeutics, Inc.. In total, 5 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €111k. History available since 3 June 2021. The latest transaction was disclosed on 4 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Vogelbaum Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
301,295 股0Common StockSEC:0001415889-24-015751:0
64,724 股0Common StockSEC:0001209191-23-034300:0
10,800 股@ US$10.28100.0% 占其流量Common StockSEC:0001209191-22-050320:0
23,752 股0Common StockSEC:0001209191-22-034624:0
14,400 股0Common StockSEC:0001209191-21-038766:0
5 条申报中的 5 条
About Vogelbaum Martin
Martin Vogelbaum is a Board Member of Cara Therapeutics, Inc. He brings valuable expertise in pharmaceutical product development. His role on the board involves guiding the company's strategic initiatives, which focus on pain management treatments.
